N-(Tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide

Catalog No. :
ACIQZF214
CAS No. :
943434-57-9
Molecular Formula :
C17H26BNO5S
Molecular Weight :
367.28

IUPAC Name:N-(tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide

N-(Tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$628.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(Tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide
IUPAC NameN-(tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide
Molecular FormulaC17H26BNO5S
Molecular Weight367.28
SMILESO=S(C1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1)(NC3CCOCC3)=O
InChI KeyNMRSRCPBCGXUBI-UHFFFAOYSA-N
SynonymN-(tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide;Benzenesulfonamide, N-(tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;N-(Tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)b...
CAS No.943434-57-9

Synthetic Route by SureRoute

1. ACIQZF214 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIQZF214 route product structure diagram
    ACIQZF214943434-57-9
Inquiry

2. ACIQZF214 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEGUA629 route compound structure diagram
    ACEGUA6291005498-91-8 In Stock
  4. Then
  5. ACIQZF214 route product structure diagram
    ACIQZF214943434-57-9
Inquiry

Comments (0)